Latest Capital Efficiency News

NEXION Group Ltd has issued 900,000 convertible notes to raise $90,000, increasing its total convertible notes to 17.5 million. The notes carry a 10% interest rate and may convert to shares subject to shareholder approval and transaction outcomes.

Premier1 Lithium has signed a non-binding Letter of Intent with Mineral Mining Services to advance the Wadgingarra project and accelerate exploration at Yalgoo, aiming to de-risk capital and speed up development.

360 Capital Mortgage REIT has introduced a voluntary Distribution Reinvestment Plan allowing unitholders to reinvest monthly distributions into additional units at net asset value without transaction costs. This move aims to enhance investor returns while maintaining capital preservation and transparency.

New Murchison Gold Limited has officially commenced production at its Crown Prince Gold Mine ahead of schedule, marking its transition from explorer to gold producer. The company aims to ramp up to a 40,000 tonne monthly ore run rate by October 2025.

RooLife Group Ltd reported a sharp 51% revenue decline to $4.62 million and a 31% increase in net loss to $2.76 million for FY2025, as it pivots towards higher-margin sectors including renewable energy and global social commerce.

Norwood Systems reported a 66.5% revenue increase to $1.9 million in FY2025, driven by a landmark five-year contract with Singtel Optus and expanding services in New Zealand. The company also narrowed its net loss by 77%, signaling improved operational momentum.

ASF Group Limited reports a dramatic turnaround to a $25.8 million profit for FY2025, driven by a one-off $32.7 million gain from subsidiary disposals amid a 70% revenue drop.

Spectur Limited reported a 6% revenue increase to $8.7 million and slashed its net loss by 70% to $779,000 in FY25, driven by operational restructuring and a shift toward recurring revenue streams.

IMEXHS reported a steady first half of FY25 with revenue up 4% and annualised recurring revenue climbing 11%, driven by strong adoption of its Aquila+ radiology platform and strategic capital raising.

Mayne Pharma Group Limited reported a robust FY25 with a 5% revenue increase to A$408.1 million and a 105% surge in underlying EBITDA, driven by strong growth in Women’s Health and strategic acquisitions in Dermatology.

NobleOak Life Limited reported robust FY25 results, with a 20% increase in in-force premiums and a 22% rise in underlying NPAT, underpinned by strategic investments in AI and a transition to a capital-efficient Life Company structure.

NobleOak Life Limited reported a robust 20% growth in in-force premiums and a 22% rise in underlying profit for FY25, surpassing guidance and setting a clear path to $1 billion in-force premium. Strategic partnerships, acquisitions, and product innovation underpin its strong outlook for FY26.